Recruiting Retinitis Pigmentosa Studies in Palo Alto
About Retinitis Pigmentosa Clinical Trials in Palo Alto
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 1 retinitis pigmentosa clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 1,314 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Palo Alto — FAQ
Are there retinitis pigmentosa clinical trials in Palo Alto?
Yes, there are 1 retinitis pigmentosa clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated October 16, 2026 from ClinicalTrials.gov